Regucalcin and metabolic disorders: Osteoporosis and hyperlipidemia are induced in regucalcin transgenic rats

Molecular and Cellular Biochemistry

Volumn 341, Issue 1-2, 2010, Pages 119-133

  Yamaguchi, Masayoshi ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone; Insulin resistance; Lipid; Lipidemia; Osteoporosis; Regucalcin; RGN; Transgenic rat

Indexed keywords

ADIPONECTIN; GLUCOSE TRANSPORTER 2; INSULIN RECEPTOR; LEPTIN; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; REGUCALCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; BONE DEVELOPMENT; BONE MINERALIZATION; DRUG EFFECT; FEMALE; GENE EXPRESSION; HYPERLIPIDEMIA; INSULIN RESISTANCE; MALE; NONHUMAN; OSSIFICATION; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; RAT; REVIEW; TRANSGENIC MOUSE;

ANIMALS; CALCIUM-BINDING PROTEINS; FEMALE; HYPERLIPIDEMIAS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; METABOLIC DISEASES; OSTEOPOROSIS; RATS; RATS, TRANSGENIC;

RATTUS;

EID: 77955009190     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-010-0443-4     Document Type: Review

References (100)

1. WY Cheung 1980 Calmodulin plays a pivotal role in cellular regulation Science 202 19 27 10.1126/science.6243188
2. Y Nishizuka 1986 Studies and perspectives of protein kinase C Science 233 305 312 10.1126/science.3014651 1:CAS:528:DyaL28XlsVKht70%3D 3014651
3. 2+ in the regulation of gluconeogenesis Metabolism 42 389 403 10.1016/S0026-0495(96) 90296-6 (Pubitemid 26102647)
4. M Yamaguchi T Yamamoto 1978 Purification of calcium binding substance from soluble fraction of normal rat liver Chem Pharm Bull 26 1915 1918 1:CAS:528:DyaE1cXlt1Ckurk%3D 699201
5. M Yamaguchi K Sugii 1981 Properties of calcium-binding protein isolated from the soluble fraction of normal rat liver Chem Pharm Bull 29 567 570 1:CAS:528:DyaL3MXhsFaitL0%3D 7273253
6. 2+-induced conformational changes Chem Pharm Bull 36 286 290 1:CAS:528:DyaL1cXhsVGksbs%3D 3378291
7. N Shimokawa M Yamaguchi 1993 Molecular cloning and sequencing of the cDNA coding for a calcium-binding protein regucalcin from rat liver FEBS Lett 327 251 255 10.1016/0014-5793(93)80998-A 1:CAS:528:DyaK3sXlvFOqt74%3D 8348951 (Pubitemid 23228561)
8. 2+-calmodulin Chem Pharm Bull 33 4489 4493 1:CAS:528: DyaL28XhslSjsQ%3D%3D 3004750
9. 2+ Chem Pharm Bull 35 2025 2029 1:CAS:528:DyaL2sXltFWltLY%3D 3664807
10. 2+ Chem Pharm Bull 35 2581 2584 1:CAS:528:DyaL2sXlsFSju78%3D 3664854
11. 2+-induced activation of succinate dehydrogenase in rat liver mitochondria Chem Pharm Bull 35 3766 3770 1:CAS:528:DyaL2sXmtlWmuro%3D 3435974
12. 2+ effect Chem Pharm Bull 36 321 325 1:CAS:528:DyaL1cXhsVKis7Y%3D 2837338
13. T Fujita K Uchida N Maruyama 1992 Purification of senescence marker protein-30 (SMP30) and its androgen-independent decrease with age in the rat liver Biochim Biophys Acta 1116 122 128 1:CAS:528:DyaK38XisFarsLY%3D 1581340
14. T Fujita T Shirasawa K Uchida N Maruyama 1992 Isolation of cDNA clone encoding rat senescence marker protein-30 (SMP30) and its tissue distribution Biochim Biophys Acta 1132 297 305 1:CAS:528:DyaK3sXltlelur0%3D 1420310
15. 2+-binding protein regucalcin and calcium inhibition. Regulatory role in liver cell function. In: Kohama K (ed) Calcium inhibition. Japan Sci Soc Press/CRC Press, Tokyo/Boca Raton, pp 19-41
16. M Yamaguchi 1998 Role of calcium-binding protein regucalcin in regenerating rat liver J Gastroentrol Hepatol 13 Suppl S106 S112 1:CAS:528:DyaK1cXntVCnu7c%3D
17. M Yamaguchi 2000 Role of regucalcin in calcium signaling Life Sci 66 1769 1780 10.1016/S0024-3205(99)00602-5 1:CAS:528:DC%2BD3cXisVSgsLg%3D 10809175 (Pubitemid 30198583)
18. Yamaguchi M (2000) The role of regucalcin in nuclear regulation of regenerating liver. Biochem Biophys Res Commun 276:1-6
19. Yamaguchi M (2002) Impact of aging on calcium channels and pumps. In: Mattson MP (ed) Calcium homeostasis and signaling in aging. Elsevier, Amsterdam, pp 47-65
20. M Yamaguchi 2005 Role of regucalcin in maintaining cell homeostasis and function Int J Mol Med 15 372 389
21. 2+-binding protein regucalcin is highly conserved in vertebrate species Int J Mol Med 6 191 196 1:CAS:528:DC%2BD3cXlsV2ksLs%3D 10891565
22. C Nikapitiya M De Zoysa HS Kang C Oh I Whang J Lee 2008 Molecular characterization and expression analysis of regucalcin in disk abalone (Haliotis discus discus): intramuscular calcium administration stimulates the regucalcin mRNA expression Comp Biochem Physiol B Biochem Mol Biol 150 117 124 10.1016/j.cbpb.2008.02.004 18372203
23. N Shimokawa Y Matsuda M Yamaguchi 1995 Genomic cloning and chromosomal assignment of rat regucalcin gene Mol Cell Biochem 151 157 163 10.1007/BF01322338 1:CAS:528:DyaK2MXptlemuro%3D 8569761
24. DL Thiselton J McDowall O Brandau J Ramser F d'Esposito SS Bhattacharga MT Ross AJ Hardcastle A Meindl 2002 An integrated, functionally annotated gene map of the DXS8026-ELK1 internal on human Xp11.3-Xp11.23: potential hotspot for neurogenetic disorders Genomics 79 560 572 10.1006/geno.2002.6733 1:CAS:528:DC%2BD38Xis1yhu7s%3D 11944989 (Pubitemid 34274298)
25. M Yamaguchi R Makino N Shimokawa 1996 The 5′end seguences and exon organization in rat regucalcin gene Mol Cell Biochem 165 145 150 10.1007/BF00229476 1:CAS:528:DyaK2sXhsFyntA%3D%3D 8979263
26. 2+-binding protein regucalcin Biochem J 329 157 163 1:CAS:528:DyaK1cXltFegsw%3D%3D 9405289
27. 2+-binding protein regucalcin gene Biochem Biophys Res Commun 269 270 278 10.1006/bbrc.2000.2275 (Pubitemid 30440289)
28. H Misawa M Yamaguchi 2002 Indentification of transcription factor in the promoter region of rat regucalcin gene: binding of nuclear factor I-A1 to TTGGC motif J Cell Biochem 84 795 802 10.1002/jcb.10082 11835404 (Pubitemid 34113118)
29. H Misawa M Yamaguchi 2001 Molecular cloning and sequencing of the cDNA coding for a novel regucalcin gene promoter region-related protein in rat, mouse and human liver Int J Mol Med 8 513 520 1:CAS:528:DC%2BD3MXotlyms70%3D 11605020
30. N Sawada M Yamaguchi 2005 A novel regucalcin gene promoter region-related protein: comparison of nucleotide and amino acid sequnces in vertebrates species Int J Mol Med 15 97 104 1:CAS:528:DC%2BD2MXmsFejuw%3D%3D 15583834
31. M Yamaguchi 2009 Novel protein RGPR-p117: its role as the regucalcin gene transcription factor Mol Cell Biochem 327 53 63 10.1007/s11010-009-0042-4 1:CAS:528:DC%2BD1MXmtlOrsr4%3D 19214710
32. KN Nejak-Bowen G Zeng X Tan B Cieply SP Monga 2009 Beta-catenin regulates vitamin C biosynthesis and cell survival in murine liver J Biol Chem 284 28115 28127 10.1074/jbc.M109.047258 1:CAS:528:DC%2BD1MXht1Sqsb3P 19690176
33. 2+-binding protein regucalcin. Transcriptional regulation by signaling factors J Biol Chem 274 1277 1285 10.1074/jbc.274.3.1277 1:CAS:528:DyaK1MXpsFKrug%3D%3D 9880496 (Pubitemid 29057940)
34. H Misawa M Yamaguchi 2000 Intracellular signaling factors-enhanced hepatic nuclear protein binding to TTGGC sequence in the rat regucalcin gene promoter: involvement of protein phosphorylation Biochem Biophys Res Commun 279 275 281 10.1006/bbrc.2000.3934 1:CAS:528:DC%2BD3cXosFGgtbY%3D 11112452
35. H Misawa M Yamaguchi 2002 Gene expression for a novel protein RGPR-p117 in various species: the stimulation by intracellular signaling factors J Cell Biochem 87 188 193 10.1002/jcb.10289 1:CAS:528:DC%2BD38Xnsl2ns78%3D 12244571
36. N Sawada M Yamaguchi 2006 Overexpression of RGPR-p117 enhances regucalcin gene promoter activity in cloned normal rat kidney proximal tubular epithelial cells: involvement of TTGGC motif J Cell Biochem 99 589 597 10.1002/jcb.20907 1:CAS:528:DC%2BD28XhtVSktLrP 16676356 (Pubitemid 44435575)
37. 2+-binding protein regucalcin mRNA expression in the cloned rat hepatoma cells (H4-II-E) J Cell Biochem 74 81 89 10.1002/(SICI)1097-4644(19990701)74:1<81::AID-JCB9>3.0.CO;2-3 1:CAS:528:DyaK1MXjslGju7k%3D 10381264 (Pubitemid 29270030)
38. T Nakagawa M Yamaguchi 2005 Hormonal regulation on regucalcin mRNA expression in cloned normal rat kidney proximal tubular epithelial NRK52E cells J Cell Biochem 95 589 597 10.1002/jcb.20422 1:CAS:528:DC%2BD2MXkslOnsL8%3D 15786489 (Pubitemid 41420187)
39. M Yamaguchi M Isogai 1993 Tissue concentration of calcium-binding protein regucalcin in rats by enzyme-linked immunoadsorbent assay Mol Cell Biochem 122 65 68 10.1007/BF00925738 1:CAS:528:DyaK3sXmt1ansL4%3D 8350865
40. N Shimokawa M Isogai M Yamaguchi 1995 Specific species and tissue differences for the gene expression of calcium-binding protein regucalcin Mol Cell Biochem 143 67 71 10.1007/BF00925928 1:CAS:528:DyaK2MXktFagsbw%3D 7776960
41. N Shimokawa M Yamaguchi 1992 Calcium administration stimulates the expression of calcium-binding protein regucalcin mRNA in rat liver FEBS Lett 305 151 154 10.1016/0014-5793(92)80884-J 1:CAS:528:DyaK38XltVyqsbs%3D 1618342
42. 2+-binding protein regucalcin in rat brain neurons: inhibitory effect on protein phosphatase activity Brain Res Bull 52 343 348 10.1016/S0361-9230(00)00270-7 1:CAS:528:DC%2BD3cXltVGqtrs%3D 10922512 (Pubitemid 30462204)
43. 2+-ATPase activity in rat heart muscle J Cell Biochem 86 184 193 10.1002/jcb.10209 1:CAS:528:DC%2BD38XksVGqsbw%3D 12112029 (Pubitemid 34595025)
44. M Yamaguchi H Misawa S Uchiyama Y Morooka Y Tsurusaki 2002 Role of endogenous regucalcin in bone metabolism: bone loss is induced in regucalcin transgenic rats Int J Mol Med 10 377 383 1:CAS:528:DC%2BD38XotVCqs78%3D 12239582
45. CJ Maia CR Santos F Schmitt S Socorro 2008 Regucalcin is expressed in rat mammary gland and prostate and down-regulated by 17beta-estradiol Mol Cell Biochem 311 81 86 10.1007/s11010-007-9697-x 1:CAS:528:DC%2BD1cXjsVGht7s%3D 18157649
46. CJ Maia CR Santos F Schmitt S Socorro 2009 Regucalcin is under-expressed in human breast and prostate cancers: effect of sex steroid hormones J Cell Biochem 107 667 676 10.1002/jcb.22158 1:CAS:528:DC%2BD1MXosFOiu7w%3D 19347872
47. T Murata N Shinya M Yamaguchi 1997 Expression of calcium-binding protein regucalcin mRNA in the cloned human hepatoma cells (HepG2): stimulation by insulin Mol Cell Biochem 175 163 168 10.1023/A:1006844815743 1:CAS:528:DyaK2sXmvVCrsr8%3D 9350048 (Pubitemid 27453350)
48. M Yamaguchi K Oishi 1995 17β-Estradiol stimulates the expression of hepatic calcium-binding protein regucalcin mRNA in rats Mol Cell Biochem 143 137 141 10.1007/BF01816947 1:CAS:528:DyaK2MXkvFWmsL8%3D 7596348
49. Y Kondo Y Inai Y Sato S Handa S Kubo K Shimokado S Goto M Nishikimi N Maruyama A Ishigami 2006 Senescence marker protein 30 functions as gluconolactonase in L-ascorbic acid biosynthesis, and its knockout mice are prone to scurvy Proc Natl Acad Sci USA 103 5723 5728 10.1073/pnas.0511225103 1:CAS:528:DC%2BD28XktFaisb4%3D 16585534
50. 2+-ATPase activity J Cell Biochem 86 520 529 10.1002/jcb.10249 1:CAS:528:DC%2BD38Xmtlels78%3D 12210758 (Pubitemid 36076169)
51. Y Morooka M Yamaguchi 2001 Suppressive role of endogenous regucalcin in the regulation of protein phosphatase activity in rat renal cortex cytosol J Cell Biochem 81 639 646 10.1002/jcb.1098 1:CAS:528:DC%2BD3MXjs1Onu7w%3D 11329618 (Pubitemid 32417088)
52. T Hunter 1995 Protein kinases and phosphatases: the Yin and Yang of protein phosphorylation and signaling Cell 80 225 236 10.1016/0092-8674(95) 90405-0 1:CAS:528:DyaK2MXjtlGnsrs%3D 7834742
53. M Yamaguchi A Igarashi S Uchiyama N Sawada 2004 Hyperlipidemia is induced in regucalcin transgenic rats with increasing age Int J Mol Med 14 647 651 1:CAS:528:DC%2BD2cXovFWntb0%3D 15375596
54. RJ Majeska RE Wuthier 1975 Studies on matrix vesicles isolated from chick epiphyseal cartilage. Association of pyrophosphatase and ATPase activities with alkaline phosphatase Biochim Biophys Acta 391 51 60 1:CAS:528: DyaE2MXktl2gtLc%3D 237558
55. Lian JB, Stein GS, Cannalis E, Roky PG, Boskey AL (1999) Bone formation: osteoblast lineage cells, growth factor, matrix protein, and the mineralization process. In: Favus MJ (ed) Primer on the metabolic bone disease and disorders of mineral metabolism, 4th edn. Lippincott Williams & Wilkins Press, New York, pp 14-29
56. C Cooper J Melton III 1992 Epidemiology of osteoporosis Trends Endocrinol Metab 3 224 229 10.1016/1043-2760(92)90032-V 1:STN:280:DC%2BD1c3kslGrsg%3D%3D 18407104
57. MN Weitzmann R Pacifici 2006 Estrogen deficiency and bone loss: an inflammatory tale J Clin Invest 116 1186 1194 10.1172/JCI28550 1:CAS:528:DC%2BD28XksVWgu70%3D 16670759
58. M Zaidi HC Blair BS Moonga E Abe CL-H Huang 2003 Osteoclastgenesis, bone resorption, and osteoclast-based therapeutics J Bone Miner Res 18 599 609 10.1359/jbmr.2003.18.4.599 12674320
59. M Yamaguchi N Sawada S Uchiyama H Misawa ZJ Ma 2004 Expression of regucalcin in rat bone marrow cells: involvement of osteoclastic bone resorption in regucalcin transgenic rats Int J Mol Med 13 437 443 1:CAS:528: DC%2BD2cXitFams7g%3D 14767576
60. S Uchiyama M Yamaguchi 2004 Bone loss in regucalcin transgenic rats: enhancement of osteoclastic cell formation from bone marrow of rats with increasing age Int J Mol Med 14 451 455 1:CAS:528:DC%2BD2cXntlWgtbY%3D 15289899
61. S Tanaka I Nakamura J-I Inoue H Oda K Nakamura 2003 Signal transduction pathways regulating osteoclast differentiation and function J Bone Miner Metab 21 123 133 10.1007/s007740300021 12720046 (Pubitemid 41184293)
62. M Yamaguchi S Uchiyama 2005 Regucalcin stimulates osteoclast-like cell formation in mouse marrow cultures J Cell Biochem 94 794 803 10.1002/jcb.20335 1:CAS:528:DC%2BD2MXhvFKgsro%3D 15578574 (Pubitemid 41420276)
63. W Zou I Hakim K Tschoep A Endres Z Bar-Shavit 2001 Tumor necrosis factor-α mediates RANK ligand stimulation of osteoclast-differentiation by an autocrine mechanism J Cell Biochem 83 70 83 10.1002/jcb.1202 1:CAS:528:DC%2BD3MXmslWitL4%3D 11500955 (Pubitemid 32835003)
64. M Yamaguchi M Kobayashi S Uchiyama 2005 Suppressive effect of regucalcin on cell differentiation and mineralization in osteoblastic MC3T3-E1 cells J Cell Biochem 96 543 554 10.1002/jcb.20524 1:CAS:528:DC%2BD2MXhtFSrt7vK 16052480 (Pubitemid 41504652)
65. T Komori H Yagi S Nomura A Yamaguchi K Sasaki K Deguchi Y Shimizu RT Bronson YH Gao M Inada M Sato R Okamoto Y Kitamura S Yoshiki T Kishimoto 1997 Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts Cell 89 755 764 10.1016/S0092-8674(00) 80258-5 1:CAS:528:DyaK2sXjs1ejtr4%3D 9182763
66. MH Lee YJ Kim HJ Kim HD Park AR Kang HM Kyung IM Sung JM Wozney HJ Kim HM Ryoo 2003 BKP-2-induced Runx2 expression is mediated by Dlx5, and TGF-beta 1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression J Biol Chem 278 34387 34394 10.1074/jbc.M211386200 1:CAS:528:DC%2BD3sXmvVCqsbg%3D 12815054 (Pubitemid 37553284)
67. CJ Lowenstein JL Dinerman SH Synder 1994 Nitric oxide: a physiologic messenger Ann Intern Med 120 227 237 1:CAS:528:DyaK2cXivFCltrg%3D 8273987
68. Y Otomo M Yamaguchi 2006 Regulatory effect of exogenous regucalcin on cell function in osteoblastic MC3T3-E1 cells: involvement of intracellular signaling factor Int J Mol Med 18 321 327 1:CAS:528:DC%2BD28XotFKhu78%3D 16820941
69. 2+)-adenosine triphosphatase in the plasma membranes of rat liver Chem Pharm Bull 36 3532 3539 1:CAS:528: DyaL1MXjsF2ksg%3D%3D 2977105
70. M Centrella TL McCarthy E Canalis 1990 Receptors for insulin-like growth factors-I and -II in osteoblast-enriched cultures from fetal rat bone Endocrinology 126 39 44 10.1210/endo-126-1-39 1:CAS:528:DyaK3cXpt1CrtQ%3D%3D 2152868
71. M Stock H Schafer M Fliegauf F Otto 2004 Identification of novel target of the bone-specific transcription factor Runx2 J Bone Miner Res 19 959 972 10.1359/jbmr.2004.19.6.959 1:CAS:528:DC%2BD2cXltFWktr4%3D 15190888 (Pubitemid 41103453)
72. DA Yohay J Zhang KM Thrailkill JM Arthur LD Quarles 1994 Role of serum in the developmental expression of alkaline phosphatase in MC3T3-E1 osteoblasts J Cell Physiol 158 467 475 10.1002/jcp.1041580311 1:CAS:528:DyaK2cXhvVyhu74%3D 8126070
73. M Yamaguchi Y Otomo S Uchiyama T Nakagawa 2008 Hormonal regulation of regucalcin mRNA expression in osteoblastic MC3T3-E1 cells Int J Mol Med 21 771 775 1:CAS:528:DC%2BD1cXnslGrt7k%3D 18506371
74. M Asagiri H Takayanagi 2007 The molecular understanding of osteoclast differentiation Bone 40 251 264 10.1016/j.bone.2006.09.023 1:CAS:528: DC%2BD2sXmtVCrtA%3D%3D 17098490 (Pubitemid 46054562)
75. RL Jilka 2007 Molecular and cellular mechanism of the anabolic effect of intermittent PTH Bone 40 1434 1446 10.1016/j.bone.2007.03.017 1:CAS:528:DC%2BD2sXlsF2ntLY%3D 17517365 (Pubitemid 46756429)
76. +/- mice Bone 41 25 32 10.1016/j.bone.2007. 03.012 (Pubitemid 46891897)
77. Y Tsurusaki M Yamaguchi 2003 Role of endogenous regucalcin in transgenic rats: suppression of protein tyrosine phosphatase and ribonucleic acid synthesis activities in liver nucleus In J Mol Med 12 207 211 1:CAS:528: DC%2BD3sXmsVektr8%3D
78. ZJ Ma M Yamaguchi 2003 Regulatory effect of regucalcin on nitric oxide synthase activity in rat kidney cortex cytosol: role of endogenous regucalcin in transgenic rats Int J Mol Med 12 201 206 12851718
79. ZJ Ma M Yamaguchi 2002 Suppressive role of endogenous regucalcin in the regulation of nitric oxide synthase activity in heart muscle cytosol of normal and regucalcin transgenic rats Int J Mol Med 10 761 766 1:CAS:528: DC%2BD38XpsVyrsb8%3D 12430004
80. M Tobisawa M Yamaguchi 2003 Role of endogenous regucalcin in brain function: suppression of cytosolic nitric oxide synthase and nuclear protein tyrosine phosphatase activities in brain tissue of transgenic rats In J Mol Med 12 581 585 1:CAS:528:DC%2BD3sXovFGgtrs%3D
81. PH Weinstock CL Bisgaier K Aalto-Setala H Radner R Ramarkrishnan S Levak-Frank AD Essenbury R Zechner JL Breslow 1995 Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase in knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes J Clin Invest 96 2555 2568 10.1172/JCI118319 1:CAS:528:DyaK28XmtVejsw%3D%3D 8675619
82. AH Lichtman SK Clinton K Iiyama PW Connelly P Libby MI Cybulsky 1999 Hyperlipidemia and atherosclerotic lesion development in LDL receptor-deficient mice fed defined semipurified diets with and without cholate Arterioscler Thromb Vasc Biol 19 1938 1944 1:CAS:528:DyaK1MXls1Oqtbw%3D 10446074
83. MC Jong LM Havekes 2000 Insights into apolipoprotein C metabolism from transgenic and gene-targeted mice Int J Tissue React 22 59 66 1:CAS:528:DC%2BD3cXlvVykt78%3D 10937355
84. SJ Koopmans MC Jong I Que VE Dahlmans H Pijl JK Radder M Frolich LM Havekes 2001 Hyperlipidemia is associated with increased insulin-mediated glucose metabolism, reduced fatty acid metabolism and normal blood pressure in transgenic mice overexpressing human apolipoprotein C1 Diabetologia 44 437 443 10.1007/s001250051641 1:CAS:528:DC%2BD3MXit1Gitb8%3D 11357474 (Pubitemid 32324354)
85. H Yagyu EP Lutz Y Kako S Marks Y Hu SY Choi A Bensadoun IJ Goldberg 2002 Very low density lipoprotein (VLDL) receptor-deficient mice have reduced lipoprotein lipase activity mass with VLDL receptor deficiency J Biol Chem 277 10037 10043 10.1074/jbc.M109966200 1:CAS:528:DC%2BD38XisVyltrY%3D 11790777 (Pubitemid 34968113)
86. JY Chen B Levy-Wilson S Goodart AD Cooper 2002 Mice expressing the human CYP7A1 gene in the mouse CYP7A1 knock-out background lock induction of CYP7A1 expression by cholesterol feeding and have increased hypercholesterolemia when fed a high fat diet J Biol Chem 277 42588 42595 10.1074/jbc.M205117200 1:CAS:528:DC%2BD38Xos1ensbw%3D 12202481 (Pubitemid 35285627)
87. S Fazio MF Linton 2001 Mouse models of hyperlipidemia and atheroscerosis Front Biosci 6 D515 D525 10.2741/Fazio 1:CAS:528:DC%2BD3MXjtFartLw%3D 11229870
88. H Ono H Shibano H Katagiri N Yahagi H Sakoda Y Onishi M Anai T Ogihara M Fujishiro AY Viana Y Fukushima M Abe N Shojima M Kikuchi N Yamada Y Oka T Asano 2003 Hepatic Akt activation induces marked hypoglycemia, hepatomegaly, and hypertriglyceridemia with sterol regulatory element binding protein involvement Diabetes 52 2905 2913 10.2337/diabetes.52.12.2905 1:CAS:528:DC%2BD3sXpsFagsLk%3D 14633850 (Pubitemid 37466859)
89. M Yamaguchi T Nakagawa 2007 Change in lipid components in the adipose and liver tissues of regucalcin transgenic rats with increasing age: suppression of leptin and adiponectin gene expression Int J Mol Med 20 323 328 1:CAS:528:DC%2BD2sXhtVWqtb3K 17671736
90. C Nakashima M Yamaguchi 2006 Overexpression of regucalcin enhances glucose utilization and lipid production in cloned rat hepatoma H4-II-E cells: involvement of insulin resistance J Cell Biochem 99 1582 1592 10.1002/jcb.21005 1:CAS:528:DC%2BD28Xht1Gks7nF 16817230 (Pubitemid 44845718)
91. C Nakashima M Yamaguchi 2007 Overexpression of regucalcin suppresses gene expression of insulin siganaling-related proteins in cloned rat hepatoma H4-II-E cells: involvement of insulin resistance Int J Mol Med 20 709 716 1:CAS:528:DC%2BD2sXhtlOiurbL 17912465
92. SS Soloman N Buss J Shull S Monnier G Majumdar J Wu IC Gerling 2005 Proteome of H4-II-E (liver) cells exposed to insulin and tumor necrosis factor-α: analysis of proteins involved in insulin resistance J Lab Clin Med 145 275 283 10.1016/j.lab.2005.02.013 (Pubitemid 40719933)
93. T Roni G Lupattelli E Mannarino 2006 The endocrine function of adipose tissue: an uptake Clin Endocrinol 64 255 365 10.1111/j.1365-2265.2006.02441.x
94. DJ Dyck GJ Heigenhauser CR Bruce 2006 The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity Acta Physiol 186 5 16 10.1111/j.1748-1716.2005.01502.x 1:CAS:528: DC%2BD28XisVans7s%3D
95. M Guerre-Millo 2002 Adipose tissue hormones J Endocrinol Invest 25 855 861 1:CAS:528:DC%2BD3sXmsFOrsQ%3D%3D 12508947
96. PJ Havel 2004 Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism Diabetes 53 5143 5151 10.2337/diabetes.53. 2007.S143
97. Y Fukaya M Yamaguchi 2005 Overexpression of regucalcin suppresses cell death and apoptosis in cloned rat hepatoma H4-II-E cells induced by insulin or insulin-like growth factor-I J Cell Biochem 96 145 154 10.1002/jcb.20485 1:CAS:528:DC%2BD2MXpvF2rsbg%3D 15880694 (Pubitemid 41420110)
98. SS Solomon SK Mishra MR Palazzolo AE Postlethwaite JM Seyer 1997 Identification of specific sites in the TNF-α molecule promoting insulin resistance in H4-II-E liver cells J Lab Clin Med 130 139 146 10.1016/S0022-2143(97)90090-1 1:CAS:528:DyaK2sXlvFejsr0%3D 9280141
99. Park H, Ishigami A, Shima T, Mizuno M, Maruyama N, Yamaguchi K, Mitsuyoshi H, Minami M, Yasui K, Itoh Y, Yoshikawa T, Fukui M, Hasegawa G, Nakamura N, Ohta M, Obayashi H, Okanoue T (2009) Hepatic senescence marker protein-30 is involved in the progression of nonalcoholic fatty liver disease. J Gastroenterol. doi: 10.1007/s00535-009-0154-3
100. G Hasegawa M Yamasaki M Kadono M Tanaka M Asano T Senmaru Y Kondo M Fukui H Obayashi N Maruyama N Nakamura A Ishigami 2010 Senescence marker protein-30/gluconolactonase deletion worsens glucose tolerance through impairment of acute insulin secretion Endocrinology 151 529 536 10.1210/en.2009-1163 1:CAS:528:DC%2BC3cXhsVOqtbw%3D 19934374